Intelligence

Guide: How to build an effective protein degrader

NanoTemper outlines four questions to ask yourself to ensure you’re on the right track Working in PROTACs, you’re tasked with the most challenging targets — that aim to address intractable diseases such as cancer, Alzheimer’s, or Parkinson’s disease. Despite the impressive promise of PROTACs, you still have to overcome many… Read More

#Intelligence #Resources

#Clinical trials #Deep learning #Start-ups

Global pharma start-up success stories

Listen to this article on the DDW Podcast: From AI to 3D deep-learning research to biologics, Lu Rahman selects some interesting global start-ups pushing the boundaries in drug discovery. Owkin French-American startup, Owkin is focussed on using artificial intelligence (AI) to discover and develop better treatments for… Read More

#Exclusive Content #Start-up Zone

#Drug discovery #Drug screening #Lead optimisation

One stop for GPCR Drug Discovery Needs

This paid-for advertorial by Eurofins Discovery appeared in Volume 23 – Issue 3, Summer 2022. In the following article, Luke Oostdyk, Lakshmi Anantharaman and Nicole Servant from Eurofins Discovery discuss how G-Protein Coupled Receptor screening and profiling can advance drug discovery programs.  The sheer number of understudied and orphan receptors in… Read More

#Exclusive Content #Intelligence

Learn new ways to identify mitochondrial liability

Drug-induced mitochondrial dysfunction has been linked to compound attrition, organ toxicity, black-box warnings, and market withdrawals. Agilent has released a mitochondrial toxicity infographic to help you discover the benefits of novel in vitro strategies for consumer safety. This infographic is designed to help: Gain a historical perspective on mitochondrial toxicity. Read More

#Intelligence #Resources

#3D modelling #Cell culture #Organoids

3D Model Systems ebook out now – Spheroids, Organoids, and Tissue Models

Culturing cells in 3D is simply a more realistic way to model how cells move and function in vitro. Spheroids, organoids, and more complex 3D systems have been invaluable to research, drug discovery, and personalised medicine. This e-book, sponsored by Corning, offers a practical guide for demystifying spheroids and organoids… Read More

#DDW eBooks

AI in drug discovery

AI in drug discovery eBook out now   This 28-page DDW eBook, sponsored by Benchling, contains exclusive insight from industry experts on how technology is driving innovation.   Key topics include:   The benefits of AI in the lab   Precision medicine… Read More

#DDW eBooks

Learn about recombinant antibody formats, expressions and applications

Advancements in antibody engineering technologies have greatly enhanced the generation of recombinant antibodies in various formats as therapeutic agents. There are already more than 100 antibody-based drugs approved by the FDA, and numerous antibodies are currently in their late-stage clinical studies. Compared to monoclonal antibodies produced using traditional hybridoma techniques,… Read More

#Resources

Cell & gene therapy – insight into the latest research 

This 28-page DDW eBook, sponsored by Bio IVT, contains exclusive insight from industry experts on: Cell & gene therapies: the challenges and trends Battling the bottleneck: leveraging education to close the advanced therapy talent gap Cell and gene therapies: Opportunities for innovation Informing strategic decision-making in early clinical development… Read More

#DDW eBooks